
Astraea
AI Operating System for Clinical Development
San Francisco, US
Astraea automates clinical trial biometrics from raw study inputs to FDA-ready outputs. The platform handles data normalization, CDISC mapping, SDTM, ADaM, TFLs, QC, and revision workflows in one auditable system, helping Phase II/III sponsors reduce months of manual programming and data management into automated, reviewable execution.
Meet the team2
The people behind Astraea
Joshua Wang
Founder
Sanmay Sarada
Founder